Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
NYU Langone Health
Maastricht University Medical Center
Sheba Medical Center
Adaptimmune
University of Texas Southwestern Medical Center
Boston Scientific Corporation
Brown University
InSightec
Institut Cancerologie de l'Ouest
Institut Cancerologie de l'Ouest
University of Kansas Medical Center
Ohio State University Comprehensive Cancer Center
University of Kentucky
University of Kentucky
Tel-Aviv Sourasky Medical Center
NSABP Foundation Inc